101 related articles for article (PubMed ID: 9274443)
1. Mitotic percentage index: a new prognostic factor for childhood medulloblastoma.
Gilbertson RJ; Jaros E; Perry RH; Kelly PJ; Lunec J; Pearson AD
Eur J Cancer; 1997 Apr; 33(4):609-15. PubMed ID: 9274443
[TBL] [Abstract][Full Text] [Related]
2. Prognostic significance of the c-erbB-2 oncogene product in childhood medulloblastoma.
Gilbertson RJ; Pearson AD; Perry RH; Jaros E; Kelly PJ
Br J Cancer; 1995 Mar; 71(3):473-7. PubMed ID: 7880726
[TBL] [Abstract][Full Text] [Related]
3. Ploidy and proliferative index in medulloblastoma: useful prognostic factors?
Tait DM; Eeles RA; Carter R; Ashley S; Ormerod MG
Eur J Cancer; 1993; 29A(10):1383-7. PubMed ID: 8398263
[TBL] [Abstract][Full Text] [Related]
4. Prognostic factors in medulloblastoma, including DNA ploidy.
Zerbini C; Gelber RD; Weinberg D; Sallan SE; Barnes P; Kupsky W; Scott RM; Tarbell NJ
J Clin Oncol; 1993 Apr; 11(4):616-22. PubMed ID: 8478656
[TBL] [Abstract][Full Text] [Related]
5. Flow cytometric DNA analysis of medulloblastoma. Prognostic implication of aneuploidy.
Tomita T; Yasue M; Engelhard HH; McLone DG; Gonzalez-Crussi F; Bauer KD
Cancer; 1988 Feb; 61(4):744-9. PubMed ID: 3338037
[TBL] [Abstract][Full Text] [Related]
6. Relation of tumor-cell ploidy to survival in children with medulloblastoma.
Gajjar AJ; Heideman RL; Douglass EC; Kun LE; Kovnar EH; Sanford RA; Fairclough DL; Ayers D; Look AT
J Clin Oncol; 1993 Nov; 11(11):2211-7. PubMed ID: 8229136
[TBL] [Abstract][Full Text] [Related]
7. DNA content and other prognostic features in childhood medulloblastoma. Proposal of a scoring system.
Schofield DE; Yunis EJ; Geyer JR; Albright AL; Berger MS; Taylor SR
Cancer; 1992 Mar; 69(5):1307-14. PubMed ID: 1739930
[TBL] [Abstract][Full Text] [Related]
8. DNA ploidy, S-phase fraction and mitotic indices as prognostic predictors of female breast cancer.
Lipponen P; Papinaho S; Eskelinen M; Klemi PJ; Aaltomaa S; Kosma VM; Marin S; Syrjänen K
Anticancer Res; 1992; 12(5):1533-8. PubMed ID: 1444217
[TBL] [Abstract][Full Text] [Related]
9. C-MYC expression in medulloblastoma and its prognostic value.
Herms J; Neidt I; Lüscher B; Sommer A; Schürmann P; Schröder T; Bergmann M; Wilken B; Probst-Cousin S; Hernáiz-Driever P; Behnke J; Hanefeld F; Pietsch T; Kretzschmar HA
Int J Cancer; 2000 Sep; 89(5):395-402. PubMed ID: 11008200
[TBL] [Abstract][Full Text] [Related]
10. Prediction of prognosis in children with medulloblastoma by using immunohistochemical analysis and tissue microarray.
Shim KW; Joo SY; Kim SH; Choi JU; Kim DS
J Neurosurg Pediatr; 2008 Mar; 1(3):196-205. PubMed ID: 18352763
[TBL] [Abstract][Full Text] [Related]
11. Importance of radiation time and dose factors on outcome for childhood medulloblastoma.
Back M; Ahern V; Berry M; Borg M; Sexton M; Cameron F; Stevens G; Allison R; Childs J; Barton M
Australas Radiol; 2005 Aug; 49(4):298-303. PubMed ID: 16026436
[TBL] [Abstract][Full Text] [Related]
12. Postoperative neoadjuvant chemotherapy before radiotherapy as compared to immediate radiotherapy followed by maintenance chemotherapy in the treatment of medulloblastoma in childhood: results of the German prospective randomized trial HIT '91.
Kortmann RD; Kühl J; Timmermann B; Mittler U; Urban C; Budach V; Richter E; Willich N; Flentje M; Berthold F; Slavc I; Wolff J; Meisner C; Wiestler O; Sörensen N; Warmuth-Metz M; Bamberg M
Int J Radiat Oncol Biol Phys; 2000 Jan; 46(2):269-79. PubMed ID: 10661332
[TBL] [Abstract][Full Text] [Related]
13. Histopathological prognostic factors in medulloblastoma: high expression of survivin is related to unfavourable outcome.
Haberler C; Slavc I; Czech T; Gelpi E; Heinzl H; Budka H; Urban C; Scarpatetti M; Ebetsberger-Dachs G; Schindler C; Jones N; Klein-Franke A; Maier H; Jauk B; Kiefer A; Hainfellner JA
Eur J Cancer; 2006 Nov; 42(17):2996-3003. PubMed ID: 16996732
[TBL] [Abstract][Full Text] [Related]
14. Leiomyosarcoma of the uterus: A clinicopathologic, DNA flow cytometric, p53, and mdm-2 analysis of 49 cases.
Blom R; Guerrieri C; Stâl O; Malmström H; Simonsen E
Gynecol Oncol; 1998 Jan; 68(1):54-61. PubMed ID: 9454661
[TBL] [Abstract][Full Text] [Related]
15. Treatment results for 149 medulloblastoma patients from one institution.
Khafaga Y; Kandil AE; Jamshed A; Hassounah M; DeVol E; Gray AJ
Int J Radiat Oncol Biol Phys; 1996 Jun; 35(3):501-6. PubMed ID: 8655373
[TBL] [Abstract][Full Text] [Related]
16. Prognostic factors in medulloblastoma.
Gilbertson RJ; Jaros EB; Perry RH; Pearson AD
Lancet; 1992 Aug; 340(8817):480. PubMed ID: 1354801
[No Abstract] [Full Text] [Related]
17. Multidrug resistance gene expression in childhood medulloblastoma: correlation with clinical outcome and DNA ploidy in 29 patients.
Chou PM; Reyes-Mugica M; Barquin N; Yasuda T; Tan X; Tomita T
Pediatr Neurosurg; 1995; 23(6):283-91; discussion 291-2. PubMed ID: 8743996
[TBL] [Abstract][Full Text] [Related]
18. DNA flow cytometry, nuclear morphometry, mitotic indices and steroid receptors as independent prognostic factors in female breast cancer.
Eskelinen M; Lipponen P; Papinaho S; Aaltomaa S; Kosma VM; Klemi P; Syrjänen K
Int J Cancer; 1992 Jun; 51(4):555-61. PubMed ID: 1601520
[TBL] [Abstract][Full Text] [Related]
19. Expression of FoxM1 is required for the proliferation of medulloblastoma cells and indicates worse survival of patients.
Priller M; Pöschl J; Abrão L; von Bueren AO; Cho YJ; Rutkowski S; Kretzschmar HA; Schüller U
Clin Cancer Res; 2011 Nov; 17(21):6791-801. PubMed ID: 21918172
[TBL] [Abstract][Full Text] [Related]
20. Histopathological and molecular prognostic markers in medulloblastoma: c-myc, N-myc, TrkC, and anaplasia.
Eberhart CG; Kratz J; Wang Y; Summers K; Stearns D; Cohen K; Dang CV; Burger PC
J Neuropathol Exp Neurol; 2004 May; 63(5):441-9. PubMed ID: 15198123
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
